Brief: Vensica Medical Secures $11M In Funding To Support Phase 2 Trials For Overactive Bladder Treatment
28/10/2024 12:02
Oct 28 (Reuters) - Trendlines Group Ltd THET.SI :
* VENSICA MEDICAL SECURES $11M IN FUNDING TO SUPPORT PHASE 2
TRIALS FOR OVERACTIVE BLADDER TREATMENT
Source text: ID:nPn614ydMa
Further company coverage: THET.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trendlines
See all newsIsrael's Trendlines Group swings to half-year pretax profit
Brief: Trendlines Says Nice Surgical Awarded U.S. Patent For Purse-String Stapler
Brief: Trendlines Group Says Elastimed Enters Strategic U.S. Distribution Agreement
Brief: Trendlines Updates On Israel Situation
Brief: Trendlines Group Proposes Placement Of Up To 83.7 Mln New Shares